Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Theriva Biologics Announces Positive Recommendation from the Independent Data Monitoring Committee of VIRAGE, the Phase 2b Clinical Trial of VCN-01 in Combination with Chemotherapy for Metastatic Panc
-
Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Stryker declares a $0.80 per share quarterly dividend
-
Twin Disc Announces Second Quarter Results
-
Reflect Scientific Inc. Addresses Rescheduled Freezer Shipment for a $40B BioPharma Company
-
CarbonBuilt Names Michelle Carvin, CFA as the Company’s Chief Financial Officer
-
Recce Pharmaceuticals Establishes Strategic Partnership in South-East Asia to Accelerate Clinical Program
-
Nékter Juice Bar Partners with Qu to Unify Ordering Channels and Drive Sustainable Growth as it Continues Nationwide Expansion
-
LifeVantage Announces Expansion of LV360 into Canada, Mexico, and European Markets
-
Helo Corp to Present at the Emerging Growth Conference on February 7, 2024
-
Rhythm Pharmaceuticals Announces Positive Reimbursement Decision in Italy for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome
-
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
-
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
-
Gorilla Technology Expands Middle East and Northern Africa Operations as Part of Global Expansion Strategy
-
Duos Granted AI Patent
-
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
-
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Vaccinex Announces Pricing of $3.7 Million PIPE Financing
-
Shepherd Raises $13.5 Million in Series A Funding to Help Insure the $10 Trillion Commercial Construction Industry
-
Forge Battery to Host Raleigh, N.C. Town Hall on Friday, February 16th
-
Freshworks Appoints Abe Smith as Chief of Global Field Operations
-
Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts
-
Frontier Airlines Announces Promotions Among Executive Leadership
-
Pliant Therapeutics to Participate in Upcoming Investor Events
-
New Survey Highlights Dire State of Nursing in 2024, Finds Optimism from Nurses Still in Profession
-
Vestaron bioinsecticide receives emergency use authorization in Greece for control of devastating tomato leafminer infestations
-
New Shopping Survey Reveals Mindful Spending Trends in 2024
-
Inspired Announces Partnership with Kambi to Provide Virtual Sports Offering to the Kambi Sportsbook
-
Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomatic GERD as the Second Naronapride Indication to Develop and Commercialize in their Licensed Territ
-
Antoine Jebara of JumpCloud Recognized as 2024 CRN Channel Chief
-
HII Declares Quarterly Dividend
-
Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer
-
Stryker declares a $0.80 per share quarterly dividend
-
Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.
-
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
-
Rush Street Interactive Announces Fourth Quarter And Year-End 2023 Earnings Release Date
-
New Survey Reveals Majority of People Would Consider Taking Weight-Loss Medications
-
Acronis End-of-Year Cyberthreats Report Uncovers 222% Surge in Email Attacks During 2023
-
Infineon and Worksport collaborate to reduce weight and cost of portable power stations with GaN
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis
-
FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis
-
Gildan Activewear Announces Date for Fourth Quarter and Full Year 2023 Earnings Release
-
Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers
-
Final terms for bonds to be listed 9th February 2024
-
Completion of subscription of convertible loans
-
Satisfactory performance in a difficult environment
-
BridgeBio Pharma and Kyowa Kirin Announce Partnership with an Upfront Payment of $100 Million for an Exclusive License on Infigratinib in Skeletal Dysplasias in Japan
-
Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers
-
FTI Delta Strengthens Media and Entertainment Capabilities with Appointment of Sebastian Blum
